Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
Executive Summary
The transfer of control in the Senate puts Sen. Orrin Hatch (R-Utah) in position to have greater influence in guiding generic drug reform legislation
You may also be interested in...
Medicare Rx “Tripartisan” Group Backing Away From $400 Bil. Cost
Proposals for a Medicare prescription drug benefit should increase the level of beneficiary cost sharing to fit within the available financial resources, Senate Finance Committee health policy director Linda Fishman told an Alliance for Health Reform forum Dec. 19 in Washington, D.C
Medicare Rx “Tripartisan” Group Backing Away From $400 Bil. Cost
Proposals for a Medicare prescription drug benefit should increase the level of beneficiary cost sharing to fit within the available financial resources, Senate Finance Committee health policy director Linda Fishman told an Alliance for Health Reform forum Dec. 19 in Washington, D.C
GPhA Adds Legislative Staffer For Republican Focus, Creates PAC
The Generic Pharmaceutical Association is adding a legislative staffer to concentrate on Republican lobbying